• α-Linolenic Acid: Precision Roles in Lipid Metabolism and Im

  2026-07-28

  Explore the distinct molecular mechanisms of α-Linolenic Acid (ALA) in lipid metabolism and immune modulation. This article delivers advanced insights for biomedical researchers, bridging metabolic pathways with translational applications not covered in previous content.

• Translational Protein Synthesis Insights with OPP: Mitochond

  2026-07-28

  Discover how O-propargyl-puromycin (OPP) is transforming protein synthesis measurement in immunology and proteomics. Drawing from mechanistic advances—such as the role of Pcbp1 in mitochondrial maintenance for antibody production—this article delivers actionable protocol guidance and strategic outlooks for translational researchers striving to quantify nascent protein synthesis in cellular and animal models.

• Tetrahydromagnolol: Precision Tool for CB2 and GPR55 Signali

  2026-07-27

  Explore how Tetrahydromagnolol, a potent peripheral CB2 receptor agonist, enables precise dissection of cannabinoid signaling and cytoskeletal remodeling. This article uniquely bridges GPCR pharmacology with advanced anti-inflammatory and metastatic mechanism studies.

• GSK343: Decoding EZH2 Inhibition and Epigenetic Control in C

  2026-07-27

  Explore how GSK343, a potent EZH2 inhibitor, advances epigenetic cancer research by revealing new mechanisms of gene repression and telomerase regulation. This article goes beyond workflows to integrate the latest mechanistic insights and assay strategies.

• DOT1L Inhibition Enhances Lenalidomide Response in Myeloma

  2026-07-26

  A recent study reveals that targeting the epigenetic regulator DOT1L in multiple myeloma reprograms innate immune signaling, thereby potentiating the anti-myeloma efficacy of lenalidomide. This mechanistic insight offers a rationale for novel combination strategies using DOT1L inhibition with immunomodulatory drugs to overcome resistance and improve outcomes in multiple myeloma research.

• AAPH (2,2'-Azobis(2-methylpropionamidine) Dihydrochloride) i

  2026-07-25

  AAPH empowers precise, reproducible modeling of oxidative stress in both biomedical and food science research. Discover stepwise workflows, advanced troubleshooting, and unique comparative advantages that make APExBIO’s AAPH a gold standard for lipid peroxidation and antioxidant evaluation.

• Placebo-Controlled Double-Blind Trial Validates Mianserin HC

  2026-07-24

  This pivotal double-blind, placebo-controlled clinical trial established that Mianserin HCl is effective in improving depressive symptoms and sleep quality in hospitalized female patients. The study provides rigorous evidence for the antidepressant and sedative properties of this 5-HT2 receptor antagonist, supporting its use in psychiatric disorder research.

• JZL184: Optimizing Monoacylglycerol Lipase Inhibition for Ne

  2026-07-24

  Explore how JZL184, a potent monoacylglycerol lipase inhibitor, enables precise endocannabinoid signaling modulation in advanced neurobehavioral assays. This article delivers actionable insight for optimizing research protocols and interpreting multidimensional pain and affective outcomes.

• Berbamine Hydrochloride in Cancer Research: NF-κB Activity I

  2026-07-23

  Berbamine hydrochloride is redefining experimental oncology by enabling precise NF-κB activity inhibition and robust ferroptosis modulation. This guide details applied workflows, troubleshooting strategies, and practical protocol enhancements for maximizing its impact, particularly in hepatocellular carcinoma and leukemia research.

• Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl

  2026-07-23

  This study demonstrates that select kinase inhibitors can both block p38α MAP kinase activity and enhance its dephosphorylation by phosphatases, revealing a dual-action mechanism. These findings provide a structural and mechanistic foundation for designing more potent and specific kinase inhibitors, with implications for targeted cancer research.

• Asunaprevir (BMS-650032): Next-Gen HCV RNA Replication Inhib

  2026-07-22

  Asunaprevir (BMS-650032) delivers nanomolar potency and broad genotype coverage for HCV NS3 protease inhibition. This guide details experimental workflows, troubleshooting strategies, and insights from recent advances to maximize research impact in hepatitis C virus studies.

• Single-Molecule Insights into Metazoan Bidirectional DNA Rep

  2026-07-22

  Terui et al. (2024) use single-molecule imaging to dissect the precise sequence of events during bidirectional DNA replication initiation in metazoa, revealing dynamic recruitment and assembly of core factors. Their findings clarify the roles of initiation factors such as TopBP1, RecQL4, and DONSON, providing a mechanistic framework for future studies of replication origin activation.

• Baricitinib (LY3009104): Applied Protocols for JAK1/2 Inhibi

  2026-07-21

  Baricitinib (LY3009104) enables precise, selective inhibition of JAK1/2 signaling in advanced inflammation and immune modulation research. This article bridges spatial proteomics findings with hands-on protocols, troubleshooting, and optimization tips, empowering researchers to dissect IL-6/STAT3 pathways and model disease with higher fidelity.

• ABT-263 (Navitoclax): Enhancing Apoptosis Assays in Oncology

  2026-07-21

  ABT-263 (Navitoclax) empowers cancer biologists to dissect apoptosis resistance and senescence bypass with precision, thanks to its potent Bcl-2 family inhibition. This article delivers experimental workflows, advanced troubleshooting, and actionable assay optimizations leveraging the unique features of ABT-263 from APExBIO.

• Fenofibrate Activates PPARα-YAP Pathway to Enlarge Aging Mou

  2026-07-20

  This study demonstrates that fenofibrate induces comparable liver enlargement and PPARα-YAP pathway activation in both adult and aging mice. The findings establish that the hepatic response to this PPARα agonist is independent of age, clarifying key mechanisms for metabolic and gerontology research.

454 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page